Bone Marrow Senescence and the Microenvironment of Hematological Malignancies

被引:20
|
作者
Hellmich, Charlotte [1 ,2 ]
Moore, Jamie A. [1 ]
Bowles, Kristian M. [1 ,2 ]
Rushworth, Stuart A. [1 ]
机构
[1] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England
[2] Norfolk & Norwich Univ Hosp NHS Trust, Dept Haematol, Norwich, Norfolk, England
来源
FRONTIERS IN ONCOLOGY | 2020年 / 10卷
基金
英国惠康基金;
关键词
senescence; cancer microenvironment; leukemia; p16INK4a; SASP; ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; CLONAL HEMATOPOIESIS; CELLULAR SENESCENCE; MULTIPLE-MYELOMA; IN-VIVO; CANCER; AGE; PROMOTES; CLEARANCE;
D O I
10.3389/fonc.2020.00230
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Senescence is the irreversible arrest of cell proliferation that has now been shown to play an important role in both health and disease. With increasing age senescent cells accumulate throughout the body, including the bone marrow and this has been associated with a number of age-related pathologies including malignancies. It has been shown that the senescence associated secretory phenotype (SASP) creates a pro-tumoural environment that supports proliferation and survival of malignant cells. Understanding the role of senescent cells in tumor development better may help us to identify new treatment targets to impair tumor survival and reduce treatment resistance. In this review, we will specifically discuss the role of senescence in the aging bone marrow (BM) microenvironment. Many BM disorders are age-related diseases and highly dependent on the BM microenvironment. Despite advances in drug development the prognosis particularly for older patients remains poor and new treatment approaches are needed to improve outcomes for patients. In this review, we will focus on the relationship of senescence and hematological malignancies, how senescence promotes cancer development and how malignant cells induce senescence.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Cell interactions in the bone marrow microenvironment affecting myeloid malignancies
    Kokkaliaris, Konstantinos D.
    Scadden, David T.
    BLOOD ADVANCES, 2020, 4 (15) : 3795 - 3803
  • [22] Tumour microenvironment heterogeneity in hematological malignancies
    Deaglio, Silvia
    Ringshausen, Ingo
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [23] EPIDEMIOLOGY OF INFECTIONS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND IN BONE-MARROW TRANSPLANTS
    DEPAUW, BE
    HOOGKAMPKORSTANJE, MAA
    BAILLIERES CLINICAL INFECTIOUS DISEASES, 1994, 1 (03): : 391 - 414
  • [24] Characteristics of bone marrow mesenchymal stromal cells in patients with hematological malignancies
    Shevela, E. Ya.
    Petrovsky, Ya. L.
    Kurganova, E. V.
    Tikhonova, M. A.
    Sakhno, L. V.
    Sergeyevicheva, V. V.
    Kulagin, A. D.
    Lisukov, I. A.
    Ostanin, A. A.
    Chernykh, E. R.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2008, 53 (02): : 32 - 37
  • [25] Allogeneic bone marrow transplantation for hematological malignancies - Controversies and recent advances
    Ringden, O
    ACTA ONCOLOGICA, 1997, 36 (06) : 549 - 564
  • [26] BONE-MARROW TRANSPLANTATION FOR TREATMENT OF HEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS
    FROMMHOLD, H
    NIEDERWIESER, D
    HUBER, C
    MARGREITER, R
    URL, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 1987, 163 (04) : 244 - 244
  • [27] Critical illness polyneuropathy in patients with bone marrow transplantation for hematological malignancies
    Openshaw, H
    Slatkin, NE
    ANNALS OF NEUROLOGY, 1997, 42 (03) : T313 - T313
  • [28] 2ND BONE-MARROW TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES
    HASHIMOTO, S
    NAKASEKO, T
    ASAI, T
    NAKAMURA, H
    OH, H
    YOSHIDA, S
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 715 - 715
  • [29] The bone marrow stromal niche: a therapeutic target of hematological myeloid malignancies
    Behrmann, Lena
    Wellbrock, Jasmin
    Fiedler, Walter
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (05) : 451 - 462
  • [30] BONE-MARROW TRANSPLANTATION IN THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS
    NIEDERWIESER, D
    AULITZKY, W
    FROMMHOLD, H
    SCHONITZER, D
    URL, M
    ALLERBERGER, F
    WIEGELE, J
    GRATWOHL, A
    BRAUNSTEINER, H
    HUBER, C
    WIENER KLINISCHE WOCHENSCHRIFT, 1987, 99 (02) : 49 - 53